Article Details
Wouldn’t it be nice to find new buyer and or seller leads in your email or voicemail, potential buyers and sellers waiting for your call or e-mail? ESIGNPOINT lead generation websites can generate buyer and seller inquiries every week. Could your production use a boost in 2011? This program has guaranteed results with no hidden cost. "no additional cost regardless of the number of leads produced" free hosting, free tech. support, free lead capture page. A limited number of territories are available upon request; check today to see if your City is available. and get your lead generation site up and running today.
Global Health Progress Report: Improve Access to Healthcare in China |
| Date Added: June 10, 2010 09:33:41 AM |
| Author: Mark Grayson |
| Category: Health |
| Global Health Progress’ recently released report, Innovative Solutions to Improving Health in China, summarizes the important role access to drugs, access to medicines and overall access to healthcare plays across the world, especially in China. Notably, the report points out China’s, as in other countries around the world, population faces the challenge of debilitating and deadly infectious and chronic diseases. For instance, in China, the HIV infection rate has been rising sharply, making HIV/AIDS the country’s leading cause of death among infectious diseases. China also has the second largest number of tuberculosis cases in the world, and its levels of drug-resistant tuberculosis are nearly twice the global average. More than half the population (700 million Chinese) has had hepatitis B, and the number of patients with diabetes is growing faster in China than anywhere else in the world. The country’s estimated 35 million to 40 million diabetics now constitute 20 percent of the world’s total. In addition to emphasizing the importance of access to prescription medications, and other healthcare solutions, the report highlights how China’s leaders have recognized the need to ensure safe, efficient, affordable access to healthcare for all of its citizens. This includes ensuring access to quality health services and an ability to rapidly respond to public health emergencies, such as the avian flu. While patient assistance programs for patented and unpatented medicines have helped reduce barriers to access to medicines, they have limited impact if challenges within a health system work to keep the medicine from reaching patients. Partnerships between industry and government are essential to effectively reach patients and meet healthcare objectives and leaders in China face complex health challenges with limited local resources. Thus, biopharmaceutical companies have worked with the Chinese government, Chinese organizations, international agencies, and local leaders for decades in building effective, sustainable programs to address many of these challenges and improve the health of Chinese citizens. Given this shared commitment, the potential for greater collaboration, and the desire to do more, biopharmaceutical companies formed Global Health Progress. The Global Health Progress is committed to working with leaders in China to strengthen collaboration with research-based biopharmaceutical companies and other global health leaders to reduce the burden of disease and strengthen health systems. Building sustainable, innovative solutions to this serious situation and improving access to healthcare calls for joint action among local leaders and diverse global stakeholders. The examples described in the full report demonstrate the progress made and the potential for new initiatives. Global Health Progress supports efforts to raise awareness and mobilize resources to address health challenges in the developing world, including access to drugs and access to healthcare, by bringing local leaders together with international health experts, policymakers, donor governments, and the private sector |
|
|
Esignpoint - Quality Directory
